IAVI Neutralizing Antibody Center Center uri icon

The Scripps Research Institute and International AIDS Vaccine Initiative (IAVI) has opened the world's first center dedicated to solving what is perhaps the most pressing problem in the field of AIDS vaccine research: eliciting antibodies that neutralize a broad range of HIV strains, known as broadly neutralizing antibodies (bnAbs).

Affiliated Research Areas